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Abstrak  
Latar belakang: Kemampuan hati mengatasi stres oksidatif dapat ditingkatkan dengan konsumsi antioksidan 
eksogen yang berasal dari alam. Penelitian ini ditujukan untuk mempelajari kemampuan hepatoprotektif dari 
ekstrak metanol  daun  Fagraea racemosa, dengan menggunakan CCL4  sebagai model sumber radikal bebas.  
Metode: Tiga kelompok perlakuan tikus Wistar  (enam ekor per  kelompok), masing-masing diberi dosis ekstrak  
berturut-turut 50, 100, 200 mg/kg bb per oral, sekali perhari selama 30 hari. CCl4 diinjeksikan intraperitoneal 
kepada ketiga kelompok , dua kali per minggu (1,5 ml/kg bb).  Sebagai pembanding, digunakan dua kelompok 
kontrol, yaitu kontrol normal dan kontrol CCl4.  Pada hari ke-30, tikus dibunuh dan hati diwarnai dengan 
hematoksilin-eosin. Perubahan histopatologi ditentukan berdasar derajat steatosis, degenerasi hidropik, dan 
inflamasi. Data dianalisis dengan Anova dan uji post hoc LSD (p≤0.05) menggunakan SPSS versi 13.0 
Hasil: Hasil menunjukkan perbaikan derajat degenerasi hidropik dan inflamasi (p≤0,05) pada ketiga kelompok 
perlakuan bila dibanding dengan kelompok kontrol CCl4. Tetapi, derajat steatosis meningkat pada kelompok 
perlakuan dosis  50 dan 100 mg/kg bb, dan kemudian menurun secara bermakna pada perlakuan 200 mg/kg bb.   
Kesimpulan : Ekstrak methanol daun Fagraea racemosa  mampu melindungi hati dari radikal bebas yang 
dihasilkan dari CCl4. Hasil ini mengindikasikan bahwa Fagraea racemosa menjanjikan untuk dikembangkan 
sebagai suplemen antioksidan. (Health Science Indones 2011;2:46-51) 
Kata kunci: ekstrak methanol,  Fagraea racemosa, hepatoprotektif  
 
Abstract  
Background: The ability of the liver in dealing with oxidative stress can be enhanced by consumption of 
exogenous antioxidants derived from nature. This study aimed to explore the hepatoprotective ability of Fagraea 
racemosa leaves methanolic extract against CCl4 exposure as a model of free radicals source. 
Methods: Three different doses (50, 100, 200 mg/kg bw) were administered orally to three treatment groups of 
Wistar rats (six Wistar rats each), respectively, once per day for 30 days. CCl4 injected intraperitoneally to those 
three groups, twice a week (1,5 ml/kg bw).  Two control groups were provided that were one normal control 
group and one CCl4 control group.  On the 30
th
 day, the rats were killed and its liver examined with 
Haematoxyllin eosin staining. Histopathological changes were graded based on the degree of steatosis, hydropic 
degeneration, and inflammation. Data were analyzed with ANOVA and LSD post hoc (p≤0.05) using SPSS 
version 13.0 
Results: The results showed improvement between the three treatment groups and the CCl4 control group about 
the degree of hydropic degeneration and inflammation (P ≤ 0.05). However, there were significant increased of 
steatosis 50 and 100 mg/kg bw treatment groups, before its significantly decrease at 200 mg/kg bw treatment 
group (2.5 g/kg). 
Conclusions: Fagraea racemosa leaves methanolic extract could protect liver from free radicals generated by 
CCl4. The result indicated that Fagraea racemosa has promising quality to be explored as antioxidant 
supplement. (Health Science Indones 2011;2:46-51) 
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Liver as the main organ of metabolism and 
detoxification have greater risk of oxidative 
stress than others. Various sources of free 
radicals in the liver produced by mitochondria 
in the oxidation phosphorylation process,  
inflammatory process, or  xenobiotics meta- 
bolism (drugs and chemical substances).
1
  In the 
state of excessive free radicals, endogenous 
antioxidants are not able to cope with oxidative 
stress, thus  needs exogenous antioxidants from 
the diet.
2
 
Borneo forest stores thousands of medicinal 
plants that have not been optimally utilized as 
an alternative medicine because of scientific 
evidence about the benefits and safety is still 
lacking.
3
 One of the interesting plants studied is 
Fagraea racemosa Jack ex Wall (F. racemosa). 
Borneo forest is overgrown by 42 Fragaea 
species, especially in secondary forest with a lot 
of sunlight. F. racemosa can be grown in 
different soil types both marshy and dry, at an 
altitude of 0000-2000 m asl.
4
 Some tribes use it 
as medicine. Dayak tribe use stems bark and 
root for heat-lowering medications and pain 
relievers. A community around Mentoko-
Bontang forest in using this plant shoots as 
ulcer treatment. Banjar tribe use the leaves for 
muscles relaxant on stroke patients.
5
 
Phytochemical and pharmacological studies on 
F. racemosa have not been much done. 
Biological activity tests of these extracts 
showed the ability of analgesics and relaxation 
of arteries through norepinephrin antagonisme.
6
 
Another study by Purwatiningsih on chloroform 
and methanol extracts from roots, root barks, 
stems, stem barks, and leaves of F. racemosa by 
measuring DPPH reduction (2,2-diphenyl-1-
picrylhydrazil), shows highest antioxidant 
ability of leaf extracts (74%) compared to other 
parts of the plant extracts.  Toxicity tests of 
methanol leaves extracts on shrimp larvae 
showed lowest toxicity compared to other parts 
of the plant extracts.
7
   
Antioxidant ability of F. racemosa leaf extracts 
in vitro need to be tested in vivo using liver as 
target organ and carbon tetrachloride (CCl4) as 
free radical generator model. CCl4 is activated 
in endoplasmik reticulum by hepatic cytoch- 
rome P450 to form trichloromethyl free radicals 
(CCl3 and / or CCl3OO
-
). 
8,9
  Covalent bond 
between trichloromethyl with cell protein is the 
first step of the chain reactions that cause lipid 
peroxidation and ultimately cause cell necrosis 
followed by inflammation process.
10
 In addition 
to acute toxicity which causes tissue damage, 
CCl4 also caused apoptosis when administered 
at low or moderate doses.
11
 Damage on cell 
membran induce hydropic degeneration on 
hepatocyte. Lipid peroxidation induce the 
damage to mitochondria, decreased ATP prod- 
uction, and damage to the sodium pump, 
thereby increasing the intracellular osmotic 
pressure.
12
 Effective antioxidant capacity of F. 
racemosa leaves extract in vivo will inhibit 
development of liver damage which indicated 
by milder necrosis, inflamation, dan hydropic 
degeneration.  
This study aimed to explore the hepato- 
protective ability of F. racemosa leaves metha- 
nolic extract against CCl4 exposure as a model 
of free radicals source. 
 
METHODS 
An experimental study was conducted on 
female Wistar rats (average age 2 months, body 
weight 150-200 g) during January–May 2008.  
Leaves of F. racemosa was collected from 
forest around Balikpapan town, part of East 
Kalimantan during February 2008, The taxo- 
nomic identification of plant materials was 
determined by an ethnobotany expert from 
Wanariset, Balikpapan. The F. racemosa leaves 
were dried in shade at room temperature and 
then ground to a fine powder with mechanic 
grinder. Then the powdered plant materials 
soaked with methanol 80% (PA from Merck) 
overnight, which is repeated several times until 
the solvent was clear. After the filtration of the 
solvent, the organic phases were independently 
concentrated under vacuum evaporator at 80
o
 C.  
The process produced pasta extract that stored 
at 4°C until used. The whole process of 
extraction took place at Forestry Laboratory 
Universitas Mulawarman, and the rest of the 
process carried out at Pharmacology Laboratory 
of Universitas Brawijaya.  
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Wistar rats were obtained from Biology 
Laboratory of Universitas Brawijaya, which 
were acclimatized for 14 days in a 12 h 
light/dark cycle at a constant room temperature 
with free access to standard pellet food and tap 
water. All experiments were carried out 
according to the guidelines for the care and use 
of experimental animals. 
13
 The protocol was 
approved by Pharmacology Laboratory of 
Universitas Brawijaya 
The animals were randomly divided into 5 
groups of six Wistar rats each. Group  I  was  
maintained  as  normal  control  received   distil- 
led aqua 5 ml/kg bw  orally.  All the animals of 
group II to V received CCl4 (Merck, diluted 1:1 
with corn oil) at dose of 1.5 ml/kg intra- 
peritoneally for twice a week. Group II animals 
were maintained as CCl4 control without any 
extract treatment. Group  III,  IV  and  V anim- 
als  were  treated  with  methanolic extract  50,  
100  and  200 mg/kg  body weight, respectively 
by oral route. The methanolic extract was 
solved in destiled aqua (1:1) and administered 
from the first day of experiment.  Administra- 
tion of CCl4 was started at the fifth (5
th
) day. 
During the period of drug treatment the rats 
were maintained under normal diet and water ad 
libitum.   
The  animals  of  all  the  groups were  sacrific- 
ed  by  ketamine  anesthesia (1 mg/kg BW on  
30
th
 day.
14
 Livers were  removed  and  preserved 
in 10% formalin solution for histopathological 
studies. 
Liver  tissues  collected  were  used  for  the  
preparation  of histopathological  slides  by  
using  microtome  and  were suitably  stained  
and  observed  under  microscope  for architec- 
tural changes. Liver tissue was processed by the 
paraffin slice technique and sections were 
stained with hematoxylin and eosin according to 
the commonly used van Gieson's method.  
The stained slices of liver tissue were subjected 
to the evaluation of steatosis, hydropic 
degeneration, and inflammation. Steatosis (fatty 
degeneration) was evaluated based on the 
number of cells containing fat droplets (foam 
cell) per 500 cells in one lobule, at 400x 
magnification. Hydropic degeneration was det- 
ermined by the number of cells contained 
hydropic vacuole per 500 cells in one lobule, 
400 x magnifications. Both were modification 
from steatohepatitis grading by Brunt.
15
  The 
level of inflammation was evaluated based on 
the number of lobules infiltrated by dense  
leukocytes using 100 x magnification, which 
was modification of Knodell criteria.
16
 Calcu- 
lations for every slide performed with 3 
replicates in different areas, using the same 
magnification.  
The mean ± S.E.M. was calculated for each 
parameter. Total variations, present  in a set of 
data were estimated by  one  way  analysis  of  
variance  (ANOVA),  followed  by Least Signi- 
ficance Different (LSD) test. SPSS version 13 
was used as statistical software. 
 
RESULTS 
During the study, no experimental animals were 
died. The average increase in animal’s body 
weight was between 10-20 grams per week. 
Weight gain was followed by adjusting the dose 
of extract and CCl4.  
The liver of rats in first group had normal 
architecture, cords of hepatocyte well preserved, 
cytoplasm not vacuolated, sinusoid well 
demarcated, no fatty change, no fatty degene- 
ration and no area of infiltration by inflam- 
matory cells (Figure 1a). Figure 1b demonstra- 
ted that CCl4 (compared to normal control 
group) induces fat droplet, hydropic vacuolation 
of cytoplasm, distended hepatocytes, compres- 
sion of sinusoids, and nuclear pyknosis.  
Administration of methanolic F. racemosa 
leaves extract to the test groups (Fig. 1c, 1d and 
1e) generally showed improvement when 
compared with CCl4 treated control group. The 
biggest extract dose in these experiment (200 
ml/kg) showed minimal damage after induced 
by CCl4. 
At the end of the 30
th
 day treatment, liver tissue 
of CCl4 treated control group showed significant 
increase in the level of hydropic degeneration, 
steatosis and inflammation compare to normal 
control. Pretreatment with F. racemosa extract 
at 50 and 100 mg/kgBW showed marked 
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decreased of hydropic degeneration and inflam- 
mation as compared to the CCl4 treated group 
(p<0.05). The maximum protection was shown 
by methanolic extract at the dose of 200 mg/kg 
bw (Table 1). 
F. racemosa extract treatment groups  at dose 
50  and 100 mg/kgBW  induced higher steatosis  
(35% and 23%, respectively) than CCl4 treated 
control group, eventhough hydropic degene-  
ration and inflamation degree decreased. But at 
the dose 200 mg/kgBW, F racemosa extract 
reduced steatosis matched with the decrease of 
hydropic degeneration and inflam- mation. 
Dose 200 mg/kg bw was also proven to reduce 
hydropic degeneration and inflammation 
optimally almost in the level of normal control 
group, only steatosis level remained signifi- 
cantly different from the normal control group 
(p<0.05).  
 
 
 
 
 
 
 
 
 
Figure 1.  Histological image of liver 
(A)  normal control group; (B) CCl4 control group; Next picture are (C) 50 mg/kgBW; (D) 100 
mg/kgBW, and 200 mg/kgBW (E) F. racemosa extract treated groups 
       White arrow: steatotic  cell, Yellow arrow: hydropic degenerate cell, Blue arrow: inflammatory cell 
 
 
 
Table 1. Interplay between treatment of methanolic extract F. racemosa leaves with liver histological change  
Groups Hydropic 
degeneration 
(cells/field of view) 
Steatosis   
(cells/field of view) 
Dense inflammation 
(lobule/field of view) 
I 
(Normal) 
0 0 0 
II 
(CCl4) 
46.75±6.5
* 
19.5±1.7321
* 
6±2
*
 
III 
(CCl4 + F. racemosa   50 mg/kg bw) 
12.5±2.0817
*,† 
26.3±1.2583
*,† 
1.75±0.5
*,†
 
IV 
(CCl4 + F. racemosa100 mg/kg bw) 
6.75±0.9574
†,‡ 
24±0.8165
 *,†,‡ 0
*,†
 
V 
(CCl4 + F. racemosa 200 mg.kg bw) 
1.5±0.5773
†,‡,§ 
9.3±0.5
*,†,‡,§ 0
*,†
 
LSD statistical analitics (p<0,05) which significantly different result from:    
*group I; 
 †
group II; 
 ‡
group
 
III; 
 §
group IV 
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DISCUSSION  
Wistar rats were selected as experimental 
animals because it widely recognized as the 
most important model for human diseases and 
disorders. They comprise the majority of all 
experimental mammals and tend to be the 
model of choice used for research into many 
diseases/disorders.
17
 Rat variations were limited 
by selected the same gender, and also more or 
less the same age and body weight.  
F. racemosa extract administration five days 
prior to treatment was intended to reach optimal 
and stable F. racemosa extract’s blood level 
given CCl4 (on the fifth day of the study). This 
method will clarify the preventive effects of F. 
racemosa extracts. The research was only tried 
out 3 doses so the effects of extracts of F. 
racemosa at higher doses were not analyzed.  
Exposure to CCl4 in group II showed clear 
intracellular vacuoles which might contain 
lipids. These vacuoles appear clear because of 
the embedding process (before haematoxyllin-
eosin staining) used solvents that dissolve 
lipids. Accumulation of intracellular lipids 
occurs because the reactive metabolites of CCl4 
(CCL3
-
, CCl3O2
-
) caused  lipid peroxidation of 
rough endoplasmik reticulum (RER) membrane 
that resulted  on released  poliribosom attached 
to it, separated into single ribosomes. Structured 
damage of poliribosom disrupts the production 
apoprotein which make lipid cannot be trans- 
ported out of hepatocytes. In the early stages of 
exposure, lipids accumulate in the smooth 
endoplasmik reticulums (SER), which appear as 
small vacuoles in the cytoplasm. If the process 
continues, the vacuole will enlarge and pushed 
the nucleus to the periphery.
18
  
Histologic change in the form of liver cells 
swelling with clear cytoplasm (hydropic 
degeneration) at the transition area between 
healthy and necrotic area, also occurs in CCl4 
exposure.
19 
Hydropic degeneration caused by  
increased membrane permeability due to lipid 
peroxidation, resulting in electrolyte imbalance 
and drive  intercellular fluid into intracellular.
20
 
Importation of water causes the cells to swell  
three times normal size, and depressed nucleus  
at the center of the cell  and become pyknotic.  
In addition, inflammatory cells mainly 
lymphocytes and neutrophil infiltrate perisentral 
and periportal. Research by Venukumar in rats 
exposed to CCl4 for 13 weeks, causes changes 
such as steatosis, necrosis sentrilobular, 
hydropic degeneration (ballooning), and fibr- 
osis.
21
 
The degree of steatosis was significantly 
increased in treatment groups of F. racemosa 
leaf extract dose 50 and 100 mg/kg bw, 
eventhough hydropic degeneration and 
inflammation decreased. The degree of steatosis 
seen increases may be caused by inhibition of 
hydropic degeneration so that the cells contain- 
ed lipid droplet can be seen clearly without 
covered by hydropic vacuoles in it. These result  
was because the F. racemosa leaf extract can 
catch metabolite trichloromethyl so it’s not  
damaging the plasma membrane that prevent 
hydropic degeneration, but still  could damaging 
endoplasmik reticulum membrane immediately 
after  formed from CCl4 biotrans- formation 
process that induce steatosis. Its indicate that at 
dose 50 and 100 mg/kg bw, F. racemosa leaf 
extract   only sufficient to block free radical that 
emerge at cytoplasm.  
At dose of 200 mg/ kg bw, there was inhibition 
of lipid peroxidation in both plasma membrane 
and poliribosom, showed by fewer foam cells 
and hydropic degeneration. A clearer marker of 
antioxidant potential of F. racemosa leaf 
extracts was 100 % inhibition of dense inflam- 
mation cells formation at doses of 50 and 100 
mg/kg bw compared to CCl4 control group. The 
absence of dense inflamation cells could be 
interpreted as the absence of necrosis. 
In conclusion, methanolic extract of F. 
racemosa leaf can inhibit liver damage induced 
by CCl4. Mechanism of liver damage caused by 
CCl4 is through the formation of free radicals, 
which allegedly scavenge by methanolic extract 
of F. racemosa leaf working as scavenger of 
free radicals. 
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